F
Fe Tubau
Researcher at University of Barcelona
Publications - 189
Citations - 8176
Fe Tubau is an academic researcher from University of Barcelona. The author has contributed to research in topics: Bacteremia & Ceftriaxone. The author has an hindex of 49, co-authored 178 publications receiving 7131 citations. Previous affiliations of Fe Tubau include Carlos III Health Institute & Bellvitge University Hospital.
Papers
More filters
Journal ArticleDOI
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez,Elena Salamanca,Marina de Cueto,Po-Ren Hsueh,Pierluigi Viale,José Ramón Paño-Pardo,Mario Venditti,Mario Tumbarello,George L. Daikos,Rafael Cantón,Yohei Doi,Felipe Francisco Tuon,Ilias Karaiskos,Elena Pérez-Nadales,Mitchell J. Schwaber,Mitchell J. Schwaber,Özlem Kurt Azap,Maria Souli,Emmanuel Roilides,Spyros Pournaras,Murat Akova,Federico Perez,Joaquín Bermejo,Antonio Oliver,Manel Almela,Warren Lowman,Benito Almirante,Robert A. Bonomo,Robert A. Bonomo,Yehuda Carmeli,Yehuda Carmeli,David L. Paterson,Álvaro Pascual,Álvaro Pascual,Jesús Rodríguez-Baño,Jesús Rodríguez-Baño,M.D. del Toro,Jorge Galvez,Marco Falcone,Alessandro Russo,Helen Giamarellou,Enrico Maria Trecarichi,Angela Raffaella Losito,E. García-Vázquez,Alicia Hernandez,J. Gómez,Germán Bou,Elias Iosifidis,N. Prim,Ferran Navarro,Beatriz Mirelis,Anna Skiada,Julia Origüen,R. San Juan,Mario Fernández-Ruiz,Nieves Larrosa,Mireia Puig-Asensio,José Miguel Cisneros,José Molina,V. González,V. Rucci,E. Ruiz de Gopegui,C. I. Marinescu,Luis Martínez-Martínez,M.C. Fariñas,M. E. Cano,Mónica Gozalo,Marta Mora-Rillo,C. Navarro-San Francisco,Carmen Peña,Silvia Gómez-Zorrilla,Fe Tubau,Athanassios Tsakris,O. Zarkotou,Anastasia Antoniadou,Garyphallia Poulakou,Johann D. D. Pitout,Deepali Virmani,J. Torre-Cisneros,Julia Guzmán-Puche,Ö. Helvaci,A. O. Sahin,Vicente Pintado,Patricia Cordero Ruiz,Michele Bartoletti,Maddalena Giannella,Evelina Tacconelli,F. Riemenschneider,Esther Calbo,Cristina Badia,M. Xercavins,Oriol Gasch,D. Fontanals,E. Jové +93 more
TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.
Journal ArticleDOI
Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia
Beatriz Rosón,Jordi Carratalà,Núria Fernández-Sabé,Fe Tubau,Frederic Manresa,Francesc Gudiol +5 more
TL;DR: Observational analysis of a prospective series of nonimmunosuppressed hospitalized adults with community-acquired pneumonia found discordant therapy is a less frequent cause of failure, which may be preventable by rational application of the current antibiotic guidelines.
Journal ArticleDOI
Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients
Carlota Gudiol,Carlota Gudiol,Marta Bodro,Marta Bodro,Antonella F. Simonetti,Fe Tubau,Eva González-Barca,M. Cisnal,Eva Domingo-Domenech,L. Jimenez,Jordi Carratalà,Jordi Carratalà +11 more
TL;DR: Although patients in the second period were more likely to need admission to the intensive-care unit, overall case-fatality rate was similar in the two periods, and the aetiology of BSI in neutropenic patients with cancer has shifted from gram-positive to gram-negative organisms.
Journal ArticleDOI
Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes
Carlota Gudiol,Carlota Gudiol,Fe Tubau,Fe Tubau,Laura Calatayud,Laura Calatayud,Carolina Garcia-Vidal,Carolina Garcia-Vidal,M. Cisnal,Isabel Sánchez-Ortega,R F Duarte,Miguel Calvo,Jordi Carratalà,Jordi Carratalà +13 more
TL;DR: MDRGNB bacteraemia was common among cancer patients, especially in those exposed to antibiotics and urinary catheter, and the most frequent mechanism of resistance was ESBL production.
Journal ArticleDOI
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Gabriel Cabot,Alain A. Ocampo-Sosa,M. Angeles Domínguez,Juan F. Gago,Carlos Juan,Fe Tubau,Cristina Rodríguez,Bartolomé Moyá,Carmen Peña,Luis Martínez-Martínez,Antonio Oliver +10 more
TL;DR: Of particular interest, in nearly all the ST175 isolates, AmpC hyperproduction was driven by a novel AmpR-activating mutation (G154R), as demonstrated by complementation studies using an ampR mutant of PAO1.